<p>US-based private equity fund Blackstone will submit a bid next week to acquire a 33.47 per cent stake in Indian drugmaker Cipla, the <em>Economic Times </em>reported on Friday, citing people in the know.</p>.<p>The stake sale will formally start the exit of the Hamied family who had founded Cipla in 1935, the report added.</p>.<p><strong>Also Read:<a href="https://www.deccanherald.com/national/national-politics/ciplas-impending-takeover-by-blackstone-should-sadden-all-of-us-says-jairam-ramesh-1243658.html"> Cipla's impending 'takeover' by Blackstone should sadden all of us, says Jairam Ramesh</a></strong></p>.<p>Cipla and Blackstone did not immediately respond to <em>Reuters'</em> request for comment.</p>.<p>The move will also trigger an open offer for an additional 26 per cent of Cipla, upon full subscription of which Blackstone would end up owning as much as 59.4 per cent of Cipla's stake, according to the report.</p>.<p>Last Month, <em>Moneycontrol</em> had reported that top shareholders of the pharma major, which includes Blackstone are in talks to sell a part of their stake to private equity players.</p>.<p>Shares of the company have risen over 14 per cent since the <em>Moneycontrol</em> report, and hit record high on Friday.</p>
<p>US-based private equity fund Blackstone will submit a bid next week to acquire a 33.47 per cent stake in Indian drugmaker Cipla, the <em>Economic Times </em>reported on Friday, citing people in the know.</p>.<p>The stake sale will formally start the exit of the Hamied family who had founded Cipla in 1935, the report added.</p>.<p><strong>Also Read:<a href="https://www.deccanherald.com/national/national-politics/ciplas-impending-takeover-by-blackstone-should-sadden-all-of-us-says-jairam-ramesh-1243658.html"> Cipla's impending 'takeover' by Blackstone should sadden all of us, says Jairam Ramesh</a></strong></p>.<p>Cipla and Blackstone did not immediately respond to <em>Reuters'</em> request for comment.</p>.<p>The move will also trigger an open offer for an additional 26 per cent of Cipla, upon full subscription of which Blackstone would end up owning as much as 59.4 per cent of Cipla's stake, according to the report.</p>.<p>Last Month, <em>Moneycontrol</em> had reported that top shareholders of the pharma major, which includes Blackstone are in talks to sell a part of their stake to private equity players.</p>.<p>Shares of the company have risen over 14 per cent since the <em>Moneycontrol</em> report, and hit record high on Friday.</p>